NCT02083133

Insulin Dosing in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis

Dosing Strategies in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis (DOSE-HD Study)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 496 (actual)
• Sponsor: Cook County Health · Other Government
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess whether the current recommendation for a 50% dose reduction in insulin for diabetic patients with a creatinine clearance (CrCl) ≤15 mL/min or on hemodialysis results in an increased number of hypoglycemic episodes.

Conditions

• Diabetes
• Hypoglycemia
• Renal Dysfunction
• Insulin Dosing

Timeline

• Start date: 2013-10-01
• Primary completion: 2017-01-15
• Completion: 2017-05-17
• First posted: 2014-03-11
• Last updated: 2023-06-22

Locations

1 site across 1 country: United States